Pyrogallol

Pyrogallol

SCHEMBL1668793

Oc1cccc(O)c1O.Oc1ccccc1O

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.86
ALOX15 P16050 4/20 0.86
LMNA P02545 4/20 0.86
HPGD P15428 3/20 0.86
HSD17B10 Q99714 3/20 0.86
CA2 P00918 3/20 0.86
EGFR P00533 2/20 0.86
FYN P06241 2/20 0.86
MMP9 P14780 2/20 0.86
RECQL P46063 2/20 0.86
TDP1 Q9NUW8 2/20 0.86
CA1 P00915 2/20 0.86
MMP2 P08253 2/20 0.86
ADAMTS4 O75173 1/20 0.86
MMP8 P22894 1/20 0.86
CA6 P23280 1/20 0.86
CDK2 P24941 1/20 0.86
MMP12 P39900 1/20 0.86
ADAMTS5 Q9UNA0 1/20 0.86
KDM4E B2RXH2 3/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrogallol SCHEMBL17964348 0.97 ALDH1A1 (0.80) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL3532 0.93
Pyrogallol SCHEMBL170157 0.93 ALDH1A1 (1.00) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL11324823 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL11661058 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL6270291 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL10986410 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL1042997 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL442053 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10
Pyrogallol SCHEMBL4884788 0.89 ALDH1A1 (0.92) ALDH1A1ALOX15LMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750405-A ALBUMIN DETECTION IN URINE WITH QUANTITATIVE ANALYSIS BAYER CORPORATION (US) 1998-05-12 US claimed
US-20220177668-A1 METHOD FOR PRODUCING HIGH VALUE-ADDED COMPOUNDS FROM POLYETHYLENE TEREPHTHALATE KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2022-06-09 US disclosed
WO-2020209607-A1 METHOD FOR PRODUCING HIGH VALUE-ADDED COMPOUNDS FROM POLYETHYLENE TEREPHTHALATE 고려대학교 산학협력단 2020-10-15 WO disclosed
CN-108267939-A Anticorrosive additive stripping liquid controlling composition 东友精细化工有限公司 2018-07-10 CN disclosed
EP-2553117-A1 METHODS FOR DETECTING RAMAN SCATTERING USING AROMATIC COMPOUNDS COMPRISING PHOSPHATE AND AT LEAST ONE NON-LASER LIGHT SOURCE Sword Diagnostics, Inc. (US) 2013-02-06 EP disclosed
WO-2012154213-A1 COFLUORONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2012-11-15 WO disclosed
EP-2485678-A1 COFERONS AND METHODS OF MAKING AND USING THEM Cornell University (US) 2012-08-15 EP disclosed
WO-2011123386-A1 METHODS FOR DETECTING RAMAN SCATTERING USING AROMATIC COMPOUNDS COMPRISING PHOSPHATE AND AT LEAST ONE NON-LASER LIGHT SOURCE KUNDU SAMAR KUMAR (US) 2011-10-06 WO disclosed
US-20110213188-A1 PRODUCTION OF PYROLYSIS OIL VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-09-01 US disclosed
WO-2011103313-A2 PRODUCTION OF PYROLYSIS OIL VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2011-08-25 WO disclosed
US-7727420-B2 Corrosion inhibiting compositions PPT RESEARCH (US) 2010-06-01 US disclosed
US-20090176685-A1 CORROSION INHIBITING COMPOSITIONS WARD IRL E 2009-07-09 US disclosed
US-20080050398-A1 Composition Comprising Beta-Defensin 2 HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2008-02-28 US disclosed
EP-0540050-B1 Increasing adhesion of dry-film photopolymerizable compositions to carriers MACDERMID IMAGING TECHNOLOGY (US) 1997-07-23 EP disclosed
EP-0750604-A1 A METHOD OF RENDERING ORGANIC COMPOUNDS SOLUBLE IN FATTY SYSTEMS, NOVEL CHEMICAL COMPLEXES OF SUCH COMPOUNDS AND VARIOUS APPLICATIONS OF THE COMPLEXES Weidner, Morten Sloth (DK) 1997-01-02 EP disclosed
WO-1995025084-A1 A METHOD OF RENDERING ORGANIC COMPOUNDS SOLUBLE IN FATTY SYSTEMS, NOVEL CHEMICAL COMPLEXES OF SUCH COMPOUNDS AND VARIOUS APPLICATIONS OF THE COMPLEXES WEIDNER MORTEN SLOTH (DK) 1995-09-21 WO disclosed
EP-0540050-A1 Increasing adhesion of dry-film photopolymerizable compositions to carriers HERCULES INCORPORATED (US) 1993-05-05 EP disclosed
CN-1020196-C Watery coating with rust NAVY REAR SERVICE TECHNOLOGY A (CN) 1993-03-31 CN disclosed
CN-1052317-A Waterborne rusted paint NAVY REAR SERVICE TECH APPARAT (CN) 1991-06-19 CN disclosed
US-4043820-A FOR DIAZOTYPE COPYING MATERIALS OZALID GROUP HOLDINGS, LIMITED (EN) 1977-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080050398-A1 Composition Comprising Beta-Defensin 2 DLK1, DSG1, DBNL ALDH1A1 2395/4885ALOX15 2042/4885LMNA 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.